Amend 007 - DISO Adenovirus - Teva Pharmaceuticals USA Inc
Contract number W6369-19A009/001/PH
Solicitation number W6369-19A009/A
Contract award date
Expiry date
Amendment date
Contract value CAD 0.00
Contract number W6369-19A009/001/PH
Solicitation number W6369-19A009/A
Contract award date
Expiry date
Amendment date
Contract value CAD 0.00
The contract will be for a period of 40 month(s), from 2020/05/20 to 2023/10/06.
This is the total value of this contract, which includes the initial contract value and the sum of all amendments.
CAD 0.00
A contracting officer can use limited tendering for specific reasons outlined in the applicable trade agreements. The reason for this contract is described below: